Torrens M - Search Results

1

Mephedrone Concentrations in Cases of Clinical Intoxication.

Papaseit E, Olesti E, de la Torre R, Torrens M, Farre M. Papaseit E, et al. Among authors: torrens m. Curr Pharm Des. 2017;23(36):5511-5522. doi: 10.2174/1381612823666170704130213. Curr Pharm Des. 2017. PMID: 28677506 Review.

2

Flunitrazepam consumption among heroin addicts admitted for in-patient detoxification.

San L, Tato J, Torrens M, Castillo C, Farré M, Camí J. San L, et al. Among authors: torrens m. Drug Alcohol Depend. 1993 May;32(3):281-6. doi: 10.1016/0376-8716(93)90093-6. Drug Alcohol Depend. 1993. PMID: 8102333

3

Consumption of buprenorphine and other drugs among heroin addicts under ambulatory treatment: results from cross-sectional studies in 1988 and 1990.

San L, Torrens M, Castillo C, Porta M, de la Torre R. San L, et al. Among authors: torrens m. Addiction. 1993 Oct;88(10):1341-9. doi: 10.1111/j.1360-0443.1993.tb02020.x. Addiction. 1993. PMID: 8251871

4

Clinical evaluation of the Triage analytic device for drugs-of-abuse testing.

de la Torre R, Domingo-Salvany A, Badia R, Gonzàlez G, McFarlane D, San L, Torrens M. de la Torre R, et al. Among authors: torrens m. Clin Chem. 1996 Sep;42(9):1433-8. Clin Chem. 1996. PMID: 8787700

5

Monitoring patterns of substance use in drug-dependent patients.

San L, Torrens M, Tato J, Castillo C, de la Torre R, Arranz B. San L, et al. Among authors: torrens m. J Subst Abuse Treat. 1998 Sep-Oct;15(5):425-30. doi: 10.1016/s0740-5472(97)00289-4. J Subst Abuse Treat. 1998. PMID: 9750999 Clinical Trial.

6

Plasma methadone concentrations as an indicator of opioid withdrawal symptoms and heroin use in a methadone maintenance program.

Torrens M, Castillo C, San L, del Moral E, González ML, de la Torre R. Torrens M, et al. Drug Alcohol Depend. 1998 Nov 1;52(3):193-200. doi: 10.1016/s0376-8716(98)00096-9. Drug Alcohol Depend. 1998. PMID: 9839145

7

Abuse liability of flunitrazepam among methadone-maintained patients.

Farré M, Terán MT, Roset PN, Mas M, Torrens M, Camí J. Farré M, et al. Among authors: torrens m. Psychopharmacology (Berl). 1998 Dec;140(4):486-95. doi: 10.1007/s002130050793. Psychopharmacology (Berl). 1998. PMID: 9888625 Clinical Trial.

8

Analytical methodology for the detection of benzodiazepine consumption in opioid-dependent subjects.

Segura M, Barbosa J, Torrens M, Farré M, Castillo C, Segura J, de la Torre R. Segura M, et al. Among authors: torrens m. J Anal Toxicol. 2001 Mar;25(2):130-6. doi: 10.1093/jat/25.2.130. J Anal Toxicol. 2001. PMID: 11300505

9

3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.

Hernández-López C, Farré M, Roset PN, Menoyo E, Pizarro N, Ortuño J, Torrens M, Camí J, de La Torre R. Hernández-López C, et al. Among authors: torrens m. J Pharmacol Exp Ther. 2002 Jan;300(1):236-44. doi: 10.1124/jpet.300.1.236. J Pharmacol Exp Ther. 2002. PMID: 11752122 Clinical Trial.

10

Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis.

Farré M, Mas A, Torrens M, Moreno V, Camí J. Farré M, et al. Among authors: torrens m. Drug Alcohol Depend. 2002 Feb 1;65(3):283-90. doi: 10.1016/s0376-8716(01)00171-5. Drug Alcohol Depend. 2002. PMID: 11841899

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

330 results

Search Page

Filters